You are here: Industry Insights > COVID-19

News List

Success of new research projects crucial to contain community spread of COVID-19 in India: Globaldat expresspharma
May 05, 2020
The main objectives of these projects are to develop solutions to reduce community transmission and identify novel targets with the help of metabolite biomarkers.
Gujarat hospitals to join WHO’s ‘Solidarity’ clinical trial expresspharma
May 05, 2020
The trial, to be conducted by the Indian Council of Medical Research (ICMR), at hospitals in Ahmedabad, Vadodara, Surat and Rajkot, will compare the effectiveness of four drugs against COVID-19.
Quotient Sciences, CytoAgents Form COVID-19 Collaboration contractpharma
May 05, 2020
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was formed by Quotient Sciences.
FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment americanpharmaceuticalreview
May 05, 2020
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
Convalescent Plasma Trial Begins as Potential Treatment for COVID-19 americanpharmaceuticalreview
May 05, 2020
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma, taken from people who have recovered from COVID-19, is effective in treating the disease.
Eiger Announces First COVID-19 Patients Dosed with Peginterferon Lambda americanpharmaceuticalreview
May 05, 2020
Eiger BioPharmaceuticals announced the first patients have been dosed in a Phase 2 study of peginterferon lambda (Lambda) in outpatients with mild COVID-19 at the Stanford University School of Medicine.
NICE joins international collaboratives to respond to COVID-19 europeanpharmaceuticalreview
May 05, 2020
NICE in the UK has announced it will partner with international collaborations to share its work on COVID-19 and develop guidelines for healthcare professionals.
Swabs Designed by Harvard Wyss Institute Enter Human Trials for COVID-19 americanpharmaceuticalreview
May 04, 2020
Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab.
Novartis Releases Q1 Results, Updates COVID-19 Global Response americanpharmaceuticalreview
May 04, 2020
Novartis reported net income increased 34% to $3.55 billion in Q1 2020. Sales increased 13% to $12.3 billion. Key growth drivers included Entresto, Zolgensma, Kisqali, and Piqray.
ProteoGenix Announces a COVID-19 Antibody Library americanpharmaceuticalreview
May 04, 2020
ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page